QuidelOrtho Corp. Stock
Price
Target price
€13.18
€13.18
15.100%
1.77
15.100%
-
04.06.26 / Tradegate
WKN: A3DNGX / Symbol: QDEL / Name: QuidelOrtho / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
QuidelOrtho Corp. Stock
A very strong showing by QuidelOrtho Corp. today, with an increase of €1.77 (15.100%) compared to yesterday's price.
Our community identified positive and negative aspects for QuidelOrtho Corp. stock for the coming years. 1 users see the criterium "Innovation" as a plus for the QuidelOrtho Corp. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | 15.100% | 17.424% | 24.000% | -51.916% | -47.300% | -83.625% | -84.598% |
| Veeva Systems A | 0.130% | 9.036% | 5.666% | -38.089% | -19.661% | -15.513% | -35.084% |
| Thermo Fisher Scientific Inc. | 1.150% | -0.789% | 4.929% | 17.359% | -16.006% | -14.501% | 12.524% |
| Boston Scientific | 2.020% | -0.190% | -13.463% | -53.151% | -48.317% | -13.079% | 21.801% |
Comments
QuidelOrtho (NASDAQ:QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $22.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $38.00 to $25.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
News
Rice Hall James Buys QuidelOrtho Stock
On Feb. 13, 2026, Rice Hall James & Associates, LLC disclosed a buy of QuidelOrtho (NASDAQ:QDEL) in the fourth quarter.
An SEC filing dated Feb. 13, 2026, shows Rice Hall James & Associates, LLC
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires
Matthew Strobeck, a Board Director at QuidelOrtho Corp. (NASDAQ:QDEL), reported the purchase of 10,000 common shares on Feb. 13, 2026, for a total transaction value of ~$240,000, as disclosed in a
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs
On November 14, New York City-based Newtyn Management disclosed a purchase of 994,332 shares of QuidelOrtho Corporation (QDEL), increasing its stake by approximately $30.4 million.
According to a